BR112013029974A2 - imunoensaio de gencitabina - Google Patents
imunoensaio de gencitabinaInfo
- Publication number
- BR112013029974A2 BR112013029974A2 BR112013029974A BR112013029974A BR112013029974A2 BR 112013029974 A2 BR112013029974 A2 BR 112013029974A2 BR 112013029974 A BR112013029974 A BR 112013029974A BR 112013029974 A BR112013029974 A BR 112013029974A BR 112013029974 A2 BR112013029974 A2 BR 112013029974A2
- Authority
- BR
- Brazil
- Prior art keywords
- gemcitabine
- immunoassay
- immunogens
- conjugates
- antibodies
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/18—Water
- G01N33/1826—Organic contamination in water
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/18—Water
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/114,218 US8426143B2 (en) | 2011-05-24 | 2011-05-24 | Gemcitabine immunoassay |
| US13/160,370 US8946392B2 (en) | 2011-05-24 | 2011-06-14 | Gemcitabine immunoassay |
| PCT/US2012/036723 WO2012161948A1 (en) | 2011-05-24 | 2012-05-07 | Gemcitabine immunoassay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013029974A2 true BR112013029974A2 (pt) | 2017-01-31 |
Family
ID=47217602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013029974A BR112013029974A2 (pt) | 2011-05-24 | 2012-05-07 | imunoensaio de gencitabina |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8426143B2 (enExample) |
| EP (1) | EP2715340A4 (enExample) |
| JP (1) | JP2014519036A (enExample) |
| CN (1) | CN103782167B (enExample) |
| BR (1) | BR112013029974A2 (enExample) |
| CA (1) | CA2836539A1 (enExample) |
| WO (1) | WO2012161948A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8426143B2 (en) * | 2011-05-24 | 2013-04-23 | Saladax Biomedical Inc. | Gemcitabine immunoassay |
| CA3007357C (en) | 2015-12-03 | 2023-12-05 | Epidestiny, Inc. | Compositions containing decitabine, 5azacytidine and tetrahydrouridine and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2010200A (en) * | 1932-11-17 | 1935-08-06 | Internat Carbonic Engineering | Sealing device for pressure containers |
| US3996344A (en) | 1972-05-15 | 1976-12-07 | Biological Developments, Inc. | Phenethylamine antigenic conjugates, their preparation, antibodies and use |
| US4016146A (en) | 1974-12-10 | 1977-04-05 | Biological Developments, Inc. | Phenethylamine antigenic conjugates, their preparation, antibodies, and use |
| US4269511A (en) | 1979-02-15 | 1981-05-26 | Abbott Laboratories | Apparatus and method for measuring the magnitude of polarization of light |
| US4420568A (en) | 1980-07-30 | 1983-12-13 | Abbott Laboratories | Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5101015A (en) | 1989-04-10 | 1992-03-31 | Abbott Laboratories | Reagents for an amphetamine-class fluorescence polarization immunoassay |
| CA2096495C (en) | 1992-06-16 | 2002-07-09 | Kathy Palmer Ordonez | Dual analyte immunoassay |
| US7829064B2 (en) | 1999-05-10 | 2010-11-09 | Immunomedics, Inc. | Anti-CD74 immunoconjugates and methods |
| FR2836995B1 (fr) * | 2002-03-05 | 2006-09-22 | Centre Nat Rech Scient | Utilisation de derives de nucleosides comportant un groupement citrate pour la production d'anticorps ayant une affinite pour des nucleosides triphosphorylees et leurs applications |
| WO2004041203A2 (en) | 2002-11-04 | 2004-05-21 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| US20060177883A1 (en) | 2005-02-08 | 2006-08-10 | Saladax Biomedical Inc. | 5-Fluoro-uracil immunoassay |
| CA2602849C (en) | 2005-03-30 | 2013-06-04 | Saladax Biomedical Inc. | Doxorubicin immunoassay |
| US8039220B2 (en) | 2008-09-17 | 2011-10-18 | Saladax Biomedical Inc. | Stabilized standards for busulfan immunoassay |
| BR112012008772A2 (pt) | 2009-10-13 | 2017-06-20 | Rexahn Pharmaceuticals Inc | sistemas poliméricos para a liberação de agentes anti-câncer |
| US8426143B2 (en) * | 2011-05-24 | 2013-04-23 | Saladax Biomedical Inc. | Gemcitabine immunoassay |
-
2011
- 2011-05-24 US US13/114,218 patent/US8426143B2/en not_active Expired - Fee Related
- 2011-06-14 US US13/160,370 patent/US8946392B2/en active Active
-
2012
- 2012-05-07 WO PCT/US2012/036723 patent/WO2012161948A1/en not_active Ceased
- 2012-05-07 CN CN201280036559.9A patent/CN103782167B/zh not_active Expired - Fee Related
- 2012-05-07 BR BR112013029974A patent/BR112013029974A2/pt not_active IP Right Cessation
- 2012-05-07 CA CA 2836539 patent/CA2836539A1/en not_active Abandoned
- 2012-05-07 JP JP2014512857A patent/JP2014519036A/ja active Pending
- 2012-05-07 EP EP20120789833 patent/EP2715340A4/en not_active Withdrawn
-
2014
- 2014-12-19 US US14/576,877 patent/US20150104818A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2715340A4 (en) | 2014-12-31 |
| CN103782167A (zh) | 2014-05-07 |
| US8946392B2 (en) | 2015-02-03 |
| WO2012161948A1 (en) | 2012-11-29 |
| US8426143B2 (en) | 2013-04-23 |
| US20120301902A1 (en) | 2012-11-29 |
| US20120301901A1 (en) | 2012-11-29 |
| CN103782167B (zh) | 2016-01-20 |
| CA2836539A1 (en) | 2012-11-29 |
| US20150104818A1 (en) | 2015-04-16 |
| EP2715340A1 (en) | 2014-04-09 |
| JP2014519036A (ja) | 2014-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012023015A2 (pt) | imunoensaios para lenalidomida e talidomida | |
| CY1122278T1 (el) | Αντι il-36r αντισωματα | |
| CY1123518T1 (el) | Ανθρωπινα αντισωματα enanti-tau | |
| BR112014012275A2 (pt) | purificação de proteína com a utilização de tampão bis-tris | |
| BR112015027812A2 (pt) | processo contínuo de multietapa para purificação de anticorpos | |
| CY1120413T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
| BR112014003501A2 (pt) | anticorpos que se ligam à integrina alfa-v beta-8 | |
| BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
| CL2014000574A1 (es) | Anticuerpo monoclonal humanizado que se une al complejo aßtcr/cd3 humano. | |
| CR20110559A (es) | Anticuerpos específicos para cadherina-17 | |
| PT2552955T (pt) | Anticorpos com afinidade modificada para fcrn que promovem a depuração de antigénios | |
| CR11783A (es) | Molecula de union al antigeno capaz de unirse repetidamente a dos o mas moleculas de antigeno | |
| BR112014012590A8 (pt) | Anticorpos anti-cd98 e métodos de uso dos mesmos | |
| CR20110238A (es) | Anticuerpos muc1* | |
| CY1115932T1 (el) | Σκευασμα αντισωματος | |
| CR20150102A (es) | Anticuerpos que se unen a il-4 y/o il-13 (divisional 2) | |
| PL3059246T3 (pl) | Zmodyfikowany region stały przeciwciała | |
| BR112014028785A2 (pt) | proteínas de ligação a antígeno de st2 | |
| UA108199C2 (uk) | АНТИТІЛО ПРОТИ α5β1 І ЙОГО ЗАСТОСУВАННЯ | |
| UY33407A (es) | Anticuerpos específicos del factor gdf8 humano | |
| CY1119154T1 (el) | Anti-vla-4 αντισωματα | |
| BR112015017354A2 (pt) | método para detectar pelo menos uma base modificada | |
| BR112015000188A2 (pt) | isolados de proteína de batata | |
| CR20130499A (es) | Anticuerpos monoclonales frente al inhibidor de la ruta del factor tisular (tfpi) | |
| BR112014002140A2 (pt) | anticorpo anti-cxcr4 e uso do mesmo para a detecção e o diagnóstico de câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |